The influence of the MAOA gene on mental disorders of the individual
Keywords:
MAOA, Polymorphism, Mental DisordersAbstract
Objective: To review and discuss scientific studies that seek the association of the polymorphism of the MAOA gene, of the uVNTR type, with mental disorders in adults. Method: An integrative review was performed according to the PRISMA model. The research followed the stages of formulation of the research question, selection of reference search databases, definition of the search strategy, evaluation of the eligibility of studies, screening and selection of articles, data extraction and compilation of results. Results: We selected 12 original articles that reported the u-VNTR polymorphism and its alleles of 2, 3, 3.5, 4 and 5 repeats in the MAOA gene, and its association with psychic disorders. Conclusion: The polymorphism of the MAOA gene of the uVNTR type is related to the functionality of the MAOA enzyme, increasing or decreasing its activity, raising or decreasing the levels of dopamine, serotonin or noradrenaline, and these changes are related to several mental disorders, such as schizophrenia, depression, aggressive antisocial behaviors, anxiety, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder and other disorders related to the expression of these neurotransmitters.
References
NILSSON KW, ÅSLUND C, COMASCO E, ORELAND L. Gene–environment interaction of monoamine oxidase A in relation to antisocial behaviour: current and future directions. Journal Of Neural Transmission. 2018; 125(11):1601-26. doi: 10.1007/s00702-018-1892-2.
LIU Z, HUANG L, LUO Xiong-Jian, WU L, LI M. MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders. Molecular Neurobiology. 2015; 53(7):4319-27. doi: 10.1007/s12035-015-9374-0.
NAOI M, RIEDERER P, MARUYAMA W. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type a mao expression. Journal Of Neural Transmission. 2015; 123(2):91-106. doi 10.1007/s00702-014-1362-4.
KARMAKAR A, GOSWAMI R, SAHA T, MAITRA S, ROYCHOWDHURY A, PANDA C, et al. Pilot study indicate role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands. BMC Medical Genetics. 2017; 18(1):2-12. doi: 10.1186/s12881-017-0469-5.
KOLLA NJ, VINETTE SA. Monoamine Oxidase A in Antisocial Personality Disorder and Borderline Personality Disorder. Current Behavioral Neuroscience Reports. 2017; 4(1):41-48. doi: 10.1007/s40473-017-0102-0.
JANSSENS ACJW, IOANNIDIS JPA, BEDROSIAN S, BOFFETTA P, DOLAN SM, DOWLING N, et al. Declaração GRIPS: Explicação e Elaboração. EUA: 2009.
PERKOVIC MN, STRAC DS, ERJAVEC GN, UZUN S, PODOBNIK J, KOZUMPLIK O, et al. Monoamine oxidase and agitation in psychiatric patients. Progress In Neuro-Psychopharmacology And Biological Psychiatry. 2016; 69:131-46. doi: 10.1016/j.pnpbp.2016.02.002.
COOKE EM, ARMSTRONG T; BOISVERT D, WELLS J, LEWIS RH, HUGHES-STAMM S, et al. The relationship between the MAOA-uVNTR polymorphism, delinquent peer affiliation, and antisocial behavior with a consideration of sex differences. Psychiatric Quarterly. 2018; 89(4):841-53, doi: 10.1007/s11126-018-9582-7.
HOLLERBACH P, JOHANSSON A, VENTUS D, JERN P, NEUMANN CS, WESTBERG L, et al. Main and interaction effects of childhood trauma and the MAOA uVNTR polymorphism on psychopathy. Psychoneuroendocrinology. 2018; 95:106-12. doi: 10.1016/j.psyneuen.2018.05.022.
KOLLA NJ, PATEL R, MEYER JH, CHAKRAVARTY MM. Association of monoamine oxidase-A genetic variants and amygdala morphology in violent offenders with antisocial personality disorder and high psychopathic traits. Scientific Reports. 2017; 7(1):1-13. doi: 10.1038/s41598-017-08351-w.
KOLLA NJ, DUNLOP K, MEYER JH, DOWNAR J. Corticostriatal Connectivity in Antisocial Personality Disorder by MAO-A Genotype and Its Relationship to Aggressive Behavior. International Journal Of Neuropsychopharmacology. 2018; 21(8):725-33. doi: 10.1093/ijnp/pyy035.
CULEJ J, GABAJ N, ŀTEFANOVIć M, KARLOVIć D. Prediction of schizophrenia using MAOA-uVNTR polymorphism: a case control study. Indian Journal Of Psychiatry. 2020; 62(1):80. doi: 10.4103/psychiatry.indianjpsychiatry_54_19.
CHANG Hsin-I, CHANG Ya-Ting, TSAI Shih-Jen, HUANG Chi-Wei, HSU Shih-Wei, LIU Mu-Em, et al. MAOA-VNTR Genotype Effects on Ventral Striatum-Hippocampus Network in Alzheimer’s Disease: analysis using structural covariance network and correlation with neurobehavior performance. Molecular Neurobiology. 2018; 56(6):4518-29. doi: 10.1007/s12035-018-1394-0.
RODRÍGUEZ‐RAMOS A, MORIANA JÁ, GARCÍA‐TORRES F, RUIZ‐RUBIO M. Emotional stability is associated with the MAOA promoter uVNTR polymorphism in women. Brain And Behavior. 2019; 9(9):1-12. doi: 10.1002/brb3.1376.
GUREEV AS, ANANIEVA ED, RUBANOVICH AV, INGLEHART RF, PONARIN ED, BORINSKAYA SA. Association of MAOA-uVNTR Polymorphism with Subjective Well-Being in Men. Russian Journal of Genetics. 2018; 54(5):562-67. doi: 10.1134/s1022795418050058.
KRAVIC N, DZANANOVIC ES, UMIHANIC MM, KULENOVIC AD, SINANOVIC O, JAKOVLJEVIC M, et al. Association analysis of MAOA and SLC6A4 gene variation in south east european war related posttraumatic stress disorder. Psychiatria Danubina. 2019; 31(2):211-18. doi: 10.24869/psyd.2019.211.
CLUKAY CJ, DAJANI R, HADFIELD K, QUINLAN J, PANTER-BRICK C, MULLIGAN CJ. Association of MAOA genetic variants and resilience with psychosocial stress: a longitudinal study of syrian refugees. Plos One. 2019; 14(7):1-19. doi: 10.1371/journal.pone.0219385.
CHECKNITA D, EKSTRÖM TJ, COMASCO E, NILSSON KW, TIIHONEN J, HODGINS S. Associations of monoamine oxidase A gene first exon methylation with sexual abuse and current depression in women. Journal of Neural Transmission. 2018; 125(7):1053-64. doi: 10.1007/s00702-018-1875-3.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista de Divulgação Científica Sena Aires

This work is licensed under a Creative Commons Attribution 4.0 International License.
-
Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.